Comments
Loading...
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock, Earnings Estimates, EPS, And Revenue
Hepion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.720
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Hepion Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Hepion Pharmaceuticals (HEPA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-16 | $-2.42 | $-2.63 | 7.98 % |
| Sep 2023 | 2023-11-20 | $-2.74 | $-2.16 | -26.9 % |
| Mar 2023 | 2023-04-10 | $-2.60 | $-2.80 | 7.14 % |
| Dec 2020 | 2021-03-31 | $0.20 | $-4.00 | 105.0 % |
Hepion Pharmaceuticals (HEPA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?
Hepion Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Hepion Pharmaceuticals (NASDAQ:HEPA)?
Hepion Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.72, which missed the estimate of $0.00.
What were Hepion Pharmaceuticals’s (NASDAQ:HEPA) revenues?
Hepion Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.